Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00745862

Enrollment

118

Registered

2008-09-03

Start date

2008-08-31

Completion date

2013-07-31

Last updated

2013-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma

Keywords

Skin

Brief summary

The purpose of this study is to examine the experiences and quality of life of women who have been treated for melanoma. By quality of life, we mean how they are feeling about different aspects of their life. In this study, we are especially interested in their feelings about survival, physical appearance and any family concerns. We will administer a series of QOL questionnaires, data sheets with many questions, to get their response to measure their feelings about these issues.

Interventions

BEHAVIORALquestionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided

This pilot study will measure illness related distress in female patients undergoing surgical treatment of cutaneous melanoma within two years of diagnosis and treatment. Areas of particular focus will be survival anxiety, family functioning/childbearing concerns, and aesthetic impact of surgery. Patients will complete a one time only set of quality of life assessments these questionnaires will take 30-45 minutes to complete.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age 18 years or older * Clinically node-negative primary cutaneous melanoma. * Patients participating must be female * Patients must have completed surgical treatment for melanoma at least 10 days ago and less than 2 years at the time of study entry.

Exclusion criteria

* Prior history of cancer with the exception of squamous or basal cell carcinoma of the skin.

Design outcomes

Primary

Measure	Time frame
To measure illness related distress regarding survival, family planning and functioning, and aesthetic satisfaction and QOL in post-surgical female patients diagnosed with clinically localized primary cutaneous melanoma.	conclusion of study

Secondary

Measure	Time frame
To examine the impact of illness related distress on QOL in women treated for clinically localized primary cutaneous melanoma.	conclusion of study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026